A Form 144 notice of proposed sale was filed on November 17, 2026, by the David & Laura Francis Joint Revocable Trust, disclosing a planned sale of 1,901 shares of SI-BONE, Inc. common stock acquired through Performance Stock Units.
Key Highlights
- Proposed sale: 1,901 shares of SI-BONE, Inc. common stock, with an aggregate market value of $44,502.41, are proposed to be sold through Morgan Stanley Smith Barney LLC.
- Acquisition: The 1,901 shares were acquired on November 15, 2026, via Performance Stock Units from the issuer, with payment dated November 15, 2026.
- Approximate sale date: November 17, 2026, on the NASDAQ exchange.
- Shares outstanding: 45,113,087 shares of SI-BONE common stock were reported as outstanding at the time of the filing.
- 10b5-1 plan: The filing indicates a Rule 10b5-1 plan adoption date of May 21, 2026, signed by Laura Francis.
- Prior three-month sales: Combined prior sales by Laura Francis and the trust in the past three months totaled shares sold across five separate transactions, including 75,000 shares on November 4, 2026, for gross proceeds of $1,897,645.10.
SI-BONE Form 144: Francis Trust Planned Share Sale and Prior Transaction History
According to the Form 144 filing, the David & Laura Francis Joint Revocable Trust (amended, dated January 3, 2003) filed a notice of proposed sale of securities with the SEC on November 17, 2026. The filing identifies Laura Francis as both a Director and Officer of SI-BONE, Inc. (NASDAQ:SIBN), which is headquartered at 88 West Plumeria Drive, San Jose, California. The 1,901 shares proposed for sale carry an aggregate market value of $44,502.41 and were acquired through Performance Stock Units from the issuer on November 15, 2026.
The filing discloses that the proposed sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. The filer reported that a Rule 10b5-1 trading plan was adopted on May 21, 2026. The filing was signed by Laura Francis.
As required by Form 144, the filing also discloses sales during the prior three months. According to the filing, Laura Francis sold 14,953 shares on November 16, 2026, for gross proceeds of $349,053.86. The trust also conducted 10b5-1 sales of 75,000 shares on November 4, 2026 ($1,897,645.10), 38,006 shares on October 12, 2026 ($762,012.70), 25,972 shares on August 24, 2026 ($522,595.60), 3,923 shares on August 21, 2026 ($78,556.90), and 51,884 shares on August 20, 2026 ($1,009,558.87).
What Was Disclosed
The Form 144 notice discloses a proposed sale of 1,901 SI-BONE common shares by the David & Laura Francis Joint Revocable Trust, acquired via Performance Stock Units on November 15, 2026, with a reported aggregate market value of $44,502.41 and a planned sale date of November 17, 2026.



Please wait processing your request...